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PathogenesisMDV-GX0101 is a ﬁeld strain of Marek's disease virus with a naturally occurring insertion of the
reticuloendotheliosis virus (REV) LTR fragment. In order to study the biological properties of REV-LTR
insertion in the MDV genome, we constructed a full-length infectious BAC clone of MDV-GX0101 strain and
deleted the LTR sequences by BAC mutagenesis. The pathogenic properties of the LTR-deleted virus were
evaluated in infected SPF birds. The study demonstrated that the LTR-deleted virus had a stronger inhibitory
effect on the growth rates of the infected birds and induced stronger immunosuppressive effects.
Surprisingly, however, the ability for horizontal transmission of the LTR-deleted virus appeared to be
signiﬁcantly weaker than its parental LTR-intact virus. Even though the precise molecular mechanisms are
still not clear, the results of our studies demonstrate that the retention of the REV-LTR in the MDV genome
decreases its pathogenic effects but increases its potential for horizontal transmission.
© 2009 Elsevier Inc. All rights reserved.Introduction
Marek's disease virus (MDV) is an alphaherpesvirus associated
with rapid-onset T-cell lymphomas in bird. The full-length 175 kb
double-stranded DNA of the viral genome encodes several genes (Lee
et al., 2000; Tulman et al., 2000), many of which are associated with
the oncogenicity of the virus. Reticuloendotheliosis viruses (REV) are
retroviruses associated with different types of hematopoietic cell
tumors in bird, following the integration into the host genome. It has
also been demonstrated that the long terminal repeat (LTR) region of
REV could be integrated into the MDV genome when REV contam-
inated cell cultures was used to grow MDV (Isfort et al., 1992, 1994;
Jones et al., 1996, 1993; Kost et al., 1993;Witter et al., 1997). Chimeric
molecules of fragments of MDV and REV can be ampliﬁed by PCR from
MDV tumor samples indicating that the genetic recombination
between two viruses can occur in vivo (Davidson and Borenshtain,
2001).
We have previously reported the isolation of two recombinant
MDV ﬁeld strains GX0101 and GD0202 from birds showing tumors
(Zhang and Cui, 2005). Both these viruses had the integration of 539-
bp REV-LTR in identical sites of the genome between nucleotide bases
“C” and “A” at positions 153175–153176 (Md5 strain) or 150991–
150992 (GA strain). As the rate of such integration events are usually
considered to be low, the isolation of two strains of chimeric virusesll rights reserved.would suggest that the integration of REV-LTR may provide some
selective advantages in replication for such viruses that resulted in
their ready isolation from the infected birds. In our primary
experiments in infected birds, we noticed that the oncogenicity of
recombinant GX0101 was higher than virulent MDV (vMDV) GA
strain but lower than very virulent MDV (vvMDV) strain Md5. By
detection of MDV-speciﬁc DNA in feather tips from sentinel in contact
birds, it was demonstrated that the horizontal transmission of
GX0101 appeared earlier than Md5 (unpublished data). It would be
interesting to ascertain the biological advantages of the REV-LTR
insertion in MDV pathogenesis at the molecular level. The best way to
determine this would be to examine the biological characteristics of
viruses from which the integrated REV-LTR sequences are precisely
deleted.
In recent years, manipulation of the large herpesvirus genomes,
including that of MDV, have been facilitated by using bacterial
artiﬁcial chromosome (BAC) vectors (Schumacher et al., 2000; Adler
et al., 2003; Petherbridge et al., 2003, 2004, 2009; Baigent et al., 2006;
Cui et al., 2008; Zhao et al., 2008; Cui et al., 2009) or cosmid vectors
(Reddy et al., 2002; Lupiani et al., 2004). BAC cloning of MDV genome
and mutagenesis has become a routine technology in recent years for
understanding functions or biological characteristics of MDV genes.
Recently, we constructed an infectious BAC clone of GX0101 strain
and showed that the reconstituted virus had very similar character-
istics as the parental virus in replication and pathogenicity (Sun et al.,
2009). Here we report further studies to examine the functional roles
of the integrated REV-LTR in the BAC clone of GX0101 virus by
mutagenesis.
Table 1
List of primers used for the deletion and veriﬁcation of LTR.
No. Primer name Sequence Details (size of the expected PCR product)
1 LTR-kanaR-Fa 5′-ttttttgttagatttaggcaagttttgcagaacctgcagggaatgtatac
CGTGTAGGCTGGAGCTGCTTC-3′
Ampliﬁcation for KanR cassette gene with MDV
sequence ﬂanking the REV-LTR (1300 bp)
LTR-kanaR-Rb 5′-taatttctgttaaattggactcaagcaataagtcgagtagatttgatggt
CATTCCGGGGATCCGTCGAC-3′
2 LTR F 5′-GTAAACCTCCCTCCCTAA-3′ Ampliﬁcation for REV-LTR with its ﬂanking
sequences of MDV (2402 bp)LTR R 5′-GTCTCAGACAAACCGCGA-3′
3 gpt Forward 5′-TTAGCGACCGGAGATTGGCGG-3′ Ampliﬁcation for gpt gene (459 bp)
gpt Reverse 5′-ATGAGCGAAAAATACATCGTC-3′
4 Meq Forward 5′-TCAGGGTCTCCCGTCACC-3′ Ampliﬁcation for MDV Meq gene (1020 bp)
Meq Reverse 5′-ATGTCTCAGGAGCCAGAG-3′
5 MDV-USIR1 5′-CCCAGCCCCTAATGTACTAC-3′ Ampliﬁcation of the junction with MDV-
and LTR-speciﬁc primers (1094 bp)REV-LTR P1 5′-CATACTGAGCCAATGGTT-3′
6 MDV-eTRSF2 5′-GCGATTCCAAACCGGTT-3′ Ampliﬁcation of the junction with MDV-
and LTR-speciﬁc primers (599 bp)REV-LTR P1 5′-CATACTGAGCCAATGGTT-3′
7 pp38 Forward 5′-AATGTCGACACCGCACGCTTTGCTC-3′ Ampliﬁcation of the pp38 gene (963 bp)
pp38 Reverse 5′-ACAGGATCCTTAATCTCCGCCTCCAAC-3′
8 gB Forward 5′-ATGCACTATTTTAGGCGG-3′ Ampliﬁcation of the gB gene (2280 bp)
gB Reverse 5′-GGGCTTTCATTGGATTGC-3′
a,bFor primers LTR-kanaR-F and LTR-kanaR-R, underlined sequences in the upper case indicate the sequences from pKD13 used to amplify the KanR gene cassette with FRT, and
sequences in bold indicate MDV sequence ﬂanking the REV-LTR insert.
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Veriﬁcation of GX0101ΔLTR-BAC
The deletion of the LTR region and integrity of the recombinant
BAC DNA were veriﬁed by PCR generated with different primer pairs
(Table 1) using puriﬁed GX0101ΔLTR and GX0101-BAC as templates.
Agarose gel electrophoresis of PCR products are shown in Fig. 2.
Identical products of all 3 MDV genes gB, Meq and pp38 were
generated by PCR on both templates, demonstrating that the
mutagenesis steps have not affected the integrity of the recombinant
BAC in these regions. Absence of the two bands representing the
chimeric regions in GX0101ΔLTR-BAC compared to GX0101-BAC
(lanes 7 and 8, or lanes 9 and 10), as well as the detection of a smaller
band with the primer pair #2 demonstrated the deletion of the REV-
LTR from GX0101ΔLTR-BAC DNA (lanes 13 and 14). The deletion of
the LTR region from this clone was further conﬁrmed by sequence
analysis.
Characterization of the reconstituted GX0101ΔLTR virus
GX0101ΔLTR virus was reconstituted by transfection of BAC DNA
into CEFs. Characteristic MDV plaques were visible 5 days post-
transfection. Morphology of the plaques produced by the two viruses
was indistinguishable from each other. Speciﬁc staining of the viral
plaqueswithMDV pp38-speciﬁc monoclonal antibody, but not control
untransfected CEFs, further conﬁrmed the speciﬁcity of the viral
plaques.Table 2
Comparisons of growth rates in birds shown by the body weight (grams) challenged





10 75.65±9.29(31)b 78.39±9.33(28)b 87.19±8.94(16)a
14 102.58±13.89(31)b 112.78±13.82(27)c 124.69±9.39(16)a
21 164.67±17.81(30)b 183.46±20.73(26)a 192.33±13.47(15)a
28 233.52±25.41(27)b 244.81±34.54(26)b 285.31±18.83(16)a
35 308.52±44.43(27)b 349.04±48.10(26)c 387.18±29.61(16)a
42 385.65±63.35(23)b 441.35±81.23(26)c 477.50±49.59(16)a
56 588.04±125.57(23)b 670.83±156.27(24)c 800.00±84.17(16)a
Body weights were measured in live birds. The numbers in the table indicate: mean±
standard deviation (sample size). Different letters (shown in superscript) indicate that the
differences were statistically signiﬁcant between groups (pb0.05).Inﬂuence of REV-LTR deletion on growth rates
To compare the pathogenicity of mutant virus with its parental
virus, we examined the growth rates of infected birds. Both viruses
strongly inhibited the growth rates of infected birds. As shown in
Table 2, body weights of birds inoculated with GX0101ΔLTR viruses
were signiﬁcantly lower (pb0.05) than that of control birds during
the whole experimental period. In addition, the growth rates in
GX0101-inoculated birds were also inhibited compared to the control
from 28 days after infection (pb0.05). Likewise, there was signiﬁcant
difference in body weights between birds inoculated with
GX0101ΔLTR or GX0101 viruses from 35 days after infection
(pb0.05). This indicated that GX0101ΔLTR infection had stronger
negative effects on growth rates than that of GX0101 virus.
Immunosuppressive effects of the two viruses
We further compared the immunosuppressive effects of the two
viruses by measuring the speciﬁc immune responses to infection with
NDV and AIV-H9. As demonstrated in Table 3, HI antibody titers to
NDV and AIV-H9 were signiﬁcantly lower in birds infected with
GX0101ΔLTR and GX0101 viruses than control birds (pb0.05).
Between the two viruses, GX0101ΔLTR showed stronger immuno-
suppressive effects than GX0101 virus although the difference was
not statistically signiﬁcant (pN0.05).
Viremia levels of birds infected with GX0101ΔLTR or GX0101 viruses
The viremia levels in 6 birds from each group were determined on
days 7, 14, 21, 28, 38, 76 and 96 post-infection. As indicated in Table 3,
the viremia levels in GX0101 virus-infected birds could be detected asTable 3
Inﬂuence of GX0101ΔLTR and GX0101 virus infections on HI antibody titers to NDV and
AIV-H9 after vaccination (X―±S).





The numbers in the table indicate: mean±standard deviation (sample size). Different
letters (shown as superscript) indicate that the differences were statistically signiﬁcant
between groups (pb0.05).
Table 4
Comparison of viremia levels between GX0101and GX0101DLTR (n=6).
Days post-infection Viremia (PFU/ml)
GX0101 GX0101ΔLTR
7 days 252.0±179.2a 0b
14 days 715.2±368.8a 100.0±47.2b
21 days 1560.0±716.2a 406.6±210.0b
28 days 4065.0±673.6a 230.0±127.2b
38 days 1186.6±507.2a 210.0±132.2b
76 days 973.4±422.6a 175.0±50.0b
94 days 990.0±390.0a 160.0±66.6b
The numbers in the table indicate: mean±standard deviation. Different letters (shown
in superscript) indicate that the differences were signiﬁcant between groups (pb0.05).
Table 5
Comparison of twoMDV strains for their ability to induce mortality and oncogenicity in
HVT-vaccinated SPF birds.
Virus strain Mortality (%) Gross tumors (%)
GX0101 9/32 (28.13) 3/32 (9.30)
GX0101ΔLTR 14/32 (43.75) 4/32 (12.50)
Control 0/16 (0.00) 0/16 (0.00)
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infected birds. The viremia levels in GX0101ΔLTR virus-infected group
were signiﬁcantly lower than that of GX0101 group during the whole
experimental period (pb0.05; Table 4).
Pathogenicity of GX0101ΔLTR and GX0101 viruses
During 100 days after challenge with the two viruses, 28.13% and
43.75% mortalities were observed in groups inoculated with GX0101
or GX0101ΔLTR viruses, respectively, while no mortality was
recorded in the control group. In addition, 9.3% and 12.5% of birds
demonstrated tumors in different tissues or organs in groups infected
with GX0101 or GX0101ΔLTR viruses, respectively (Table 5). These
results showed that the mortality and oncogenicity of GX0101 virus
were lower than that of GX0101ΔLTR virus, although the difference
was not signiﬁcant (pN0.05).
Horizontal transmission ability of the two viruses
GX0101 virus reconstituted from the BAC clone retained its ability
for horizontal transmission. This allowed us to examine the ability of
the GX0101ΔLTR virus for bird to bird transmission. In birds,
challenged with GX0101ΔLTR or GX0101 viruses at 5 days of age,
MDV-1-speciﬁc pp38DNA could be detected in feather tips by dot blot
hybridization from 10 to 14 days after challenge no matter whether
they were vaccinated (Experiment 1) or not (Experiment 2) with HVT
at 1 day of age (Table 6). Furthermore, MDV DNA was also detected in
the feather tips of sentinel in contact birds in both groups, but the
horizontal transmission was detected 1 week earlier for GX0101 than
for GX0101ΔLTR. As indicated in Table 6, MDV DNA was detected in
isolators #1 with GX0101 of both experiments from 21 days post-
infection and the detection rates were increased during 28–35 days
post-infection. However, MDV DNA was detected in isolators #2 with
GX0101ΔLTR of both experiments from 28 days post-infection. The
frequency of horizontal transmission was higher for GX0101 than for
GX0101ΔLTR virus, although the difference was not statistically
signiﬁcant. These results showed slightly reduced transmission of
GX0101ΔLTR virus suggesting that the LTR in MDV genome might
contribute to virus horizontal transmission.
Discussion
Genetic recombination betweenMDV and REV in chicken cells was
ﬁrst demonstrated whenMDVwas passed in a REV-contaminated cell
culture (Isfort et al., 1992; Jones et al., 1993). The GX0101 strain of
MDVwas the ﬁrst ﬁeld isolate with an LTR insert of REV origin (Zhang
and Cui, 2005). GX0101 demonstrated strong oncogenicity in
unvaccinated or even in HVT-vaccinated birds (Sun et al., 2009).
The rate of recombination between MDV and REV is usually very low.
However, we successfully isolated two strains of MDV with the
identical REV-LTR inserts from two different farms in 2001 and 2002.
Another recombinant ﬁeld strain (GD0202) has the identical REV-LTRinsert at the exact same insertion site as GX0101 (Zhang and Cui,
2005). The strain GX0101was isolated from layer chicken from a farm
in Guangxi Province, and GD0202 was isolated from a breeder ﬂock of
a local breed in Guangdong Province in 2002. There was very little
opportunity for direct contact between these two ﬂocks, although
both provinces are in South China. This implied that these two
recombinant ﬁeld strains of MDV may come from a common ancestor
that has spread into different farms in South China. Although the
recombination event is generally considered to be a rare event, the
spread of such viruses demonstrated by their frequent isolation from
different areas suggested that the recombinant viruses may have a
selective advantage to become an established virus in bird ﬂocks.
In our previous studies, it was demonstrated that the pathogenic-
ity of GX0101 was lower than vvMDV strain Md5, but its horizontal
transmission ability was higher than Md5 (unpublished data). We
speculated that the higher horizontal transmission ability, perhaps
through increased replicative ﬁtness, might be the selective advan-
tage compared to its parent GX0101 virus. In order to investigate this
potentially interesting phenomenon, we cloned the strain as an
infectious BAC and carried out mutagenesis to delete the REV-LTR to
compare the biological characteristics of the reconstituted viruses
with and without the LTR. This is the ﬁrst report where the roles of
retroviral insertions into the herpesvirus genomes have been
examined by precisely deleting the LTR sequences using molecular
methods. The results indicated that the pathogenicity of the REV-LTR
deleted GX0101ΔLTR virus was slightly higher than its parental
GX0101 clone based on several parameters, such as growth
retardation, immunosuppression, mortality and tumorogenicity. As
demonstrated in Table 2, the growth rates of birds inoculated with
GX0101ΔLTR virus were signiﬁcantly lower than those infected with
the parental GX0101 virus (pb0.05). However, the differences in
immunosuppression and mortality rates in birds infected with
GX0101ΔLTR or GX0101 viruses were not signiﬁcant (Tables 3 and
5). The viremia levels in birds inoculated with GX0101ΔLTR virus was
always signiﬁcantly lower than that in GX0101 virus-infected birds
(Table 5). The viremia levels may be one of important factors
inﬂuencing horizontal transmission ability, but other factors such as
maturity of infectious viral particles may also be involved. Viral DNA
dynamics in feather tips of in-contact birds could be a direct
parameter to compare horizontal transmission ability between
GX0101 and GX0101ΔLTR viruses. Demonstration of viral DNA in
the feather tip of infected birds and the infection of sentinel in contact
birds showed that the reconstituted viruses from the parent and the
mutant BAC clones could spread horizontally. This is clearly distinct
from the previously described BAC clone of the RB-1B strain, which
was defective in horizontal spread (Petherbridge et al., 2004). The
horizontal transmission of GX0101ΔLTR virus was delayed for a week,
although MDV DNAwas detectable from feather tips at the same time
after inoculation with both viruses (Table 6). The results ﬁtted well
with the hypothesis that pathogenicity of MDV is not parallel to its
horizontal transmission ability and with insertion of REV-LTR can
increase its in vivo replication and horizontal transmission. Although
it was not a signiﬁcant difference, the detection of GX0101 DNA in
feather tips of a few (2/15) in-contact birds 1 week earlier than those
infected with GX0101ΔLTR virus was repeatable in two independent
experiments (Table 6) and could be recognized as a real phenomenon.
It may not be expected that a signiﬁcant difference in horizontal
Table 6
Dynamics of different MDV strains detected from the feather tips of MDV-infected or uninfected birds.
Experiment
number
Virus strain and group Number (%) of feather tip samples positive for MDV genomic DNA
7 days 10 days 14 days 21 days 28 days 35 days
































































































































Experiment 1, birds vaccinated with HVT at 1 day of age were challenged with GX0101ΔLTR or GX0101 virus, while sentinel in contact birds was not vaccinated. All birds in
Experiment 2 were not vaccinated with HVT. NC, negative control.
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with or without REV-LTR inserts in one infectious cycle in birds.
However, such small differences can give a cumulative effect in the
continuous transmission cycles that occur in the ﬁeld. We suggest
that, for viruses with lower pathogenicity (less mortality after
infection) but increased replicative ability, the increased viral release
rates and horizontal transmission ability should provide some
selective advantages over other viruses to become the more prevalent
ﬁeld strain. In this study, GX0101 demonstrated signiﬁcantly higher
viremia titers and relatively lower pathogenicity but higher horizontal
transmission ability than GX0101ΔLTR. It may have provided some
selective advantages for it to become the predominant strain that
could be isolated at higher frequency.
An MDV mutant strain RM1 with a REV-LTR insert was attenuated
for oncogenicity but not for its immunosuppressive effect or in vivo
replication (Witter et al., 1997). The recombinant ﬁeld strain GX0101,
also with a REV-LTR, retained its oncogenicity. The difference in
pathogenicity between these recombinant viruses is likely to be due
to the location of the REV-LTR inserts in their genomes, although other
determinants may also be involved. Several reports of REV-LTR
integrated MDV viruses isolated from cell culture indicated that the
integration sites of REV are not restricted to a particular site but are in
a clustered region around the IRS/US junction in the MDV genome,
with usually the LTR the only remnant sequence left in the genome
(Kost et al., 1993; Isfort et al., 1994; Jones et al., 1996; Witter et al.,
1997). The LTR from REV is a strong promoter or enhancer, and it may
transactivate different genes depending on the location of the
insertion (Jones et al., 1996). For example, the insertion site of the
recombinant virus RM1 with a REV-LTR was located at 370-bp
upstream of the IRS/US junction (at corresponding position 152175 in
the published sequence of the Md5 genome). Another recombinant
MDV strain had its REV-LTR inserted at the US/TRS junction at
corresponding position 164021 in the published sequence of the Md5
genome. In the recombinant ﬁeld strain GX0101 reported here, the
REV-LTR insert of 539 bp was located at its right end of IRS region
between C and A relative to the nucleotide positions 153175–153176
of the Md5 strain (our unpublished data), it was 1 kb downstream
compared to that of the RM-1 strain. The distinct differences in some
biological characteristics of different viruses with various REV-LTR
inserts may be attributed to the differences in the positions of the
retroviral insertions, such as expression of SOFR2, which is justdownstream to the insert in GX0101. The construction of a pair of BAC




MDV GX0101 is a ﬁeld strain isolated from a layer farm in Guangxi
Province of China, which contains an LTR fragment of REV integrated
into its genome (Zhang and Cui, 2005). Infectious BAC-derived
GX0101 virus was previously rescued by transfection of the BAC
DNA into chicken embryo ﬁbroblast cultures (CEFs; Sun et al. 2009).
Construction of GX0101ΔLTR-BAC
The steps used for the construction of REV-LTR-deleted GX0101-
BAC clone are shown schematically in Fig. 1. Escherichia coli (E. coli)
EL250 cells transformed with GX0101-BAC containing the whole
genome of GX0101 were prepared by inoculating a fresh overnight
culture into 10 ml of Luria-Bertani (LB) medium containing
chloramphenicol (25 μg/ml) until an optical density at 600 nm of
0.5 was reached. Then, expression of recE, recT, and λ gam was
induced by 42 °C for 15 min and collected for preparing electro-
competent cells by a standard protocol (Muyrers et al., 1999;
Narayanan et al., 1999). KanR cassette ﬂanked by FRT sites was
ampliﬁed using primers LTR-kanaR-F and LTR-kanaR-R (primer pair
#1, Table 1) from pKD13 (Datsenko and Wanner, 2000). After
digesting with DpnI to remove the residual pKD13 template, the
PCR products were puriﬁed using Gel extraction kit (OMEGA,
#F27HS). About 300 ng of the PCR products were electroporated
into 50 μl of electrocompetent EL250 cells harboring the GX0101-BAC
using standard electroporation parameters (2.0 kV, 200 Ω and 25 μF).
After electroporation, the cells were grown in 1ml of SOCmedium (2%
trypton, Oxoid; 0.5% yeast extract, Oxoid; 0.05% NaCl; 2.5 mM KCl; 10
mM MgCl; 20 mM glucose) for 2 h and spread onto LB agar plates
containing chloramphenicol (25 μg/ml) and kanamycin (50 μg/ml).
Resistant colonies were picked and grown in liquid LB medium.
Excision of the KanR cassette was carried out by induction of FLPe
recombinase by adding 0.1% arabinose into the medium. The EL250
cells harboring GX0101ΔLTR-BAC were grown up and the BAC DNA
Fig. 1. Schematic illustration of mutagenesis of GX0101 BAC to remove LTR sequences.
(A) GX0101 clone was transformed into EL250 cells that contain a defective prophage
with recombination proteins exo, bet, and gam. (B) KanR cassette ﬂanked by FRT sites
was ampliﬁed using primers that also contained 50-nt homology arms from MDV
bordering the LTR deletion and from the plasmid pKD13 and a 1.3-kb PCR product was
electroporated into the EL250 cells transformed with the GX0101 construct. (C)
Bacterial suspensions were plated on agar containing 50 μg/ml of kanamycin and 25
μg/ml of chloramphenicol, and double-resistant colonies were selected for further
analysis. (D) Kanamycin gene was ﬂipped out by the addition of 0.1% arabinose.
Fig. 2. Comparison of PCR products with different primers between GX0101 and
GX0101DLTR clones. (A) Demonstration of PCR products to conﬁrm the integrity of
MDV genome in two BAC clones. For the products shown in lanes 1, 3, 5, 7, 9, 11 and 13,
GX0101 BAC DNAwas used as the template, while the PCR products shown in lanes 2, 4,
6, 8, 10, 12 and 14 were ampliﬁed using GX0101ΔLTR DNA as the template. Lanes 1 and
2—primer pair #4 was used for the ampliﬁcation of the 1020-bp Meq gene product;
lanes 3 and 4—primer pair #7 was used for ampliﬁcation of the 963-bp pp38 gene; lanes
5 and 6—primer pair #3 was used for ampliﬁcation of the 496-bp gpt gene of the BAC
vector; lanes 7 and 8—primer pair #5 in Table 1 was used for the ampliﬁcation of the
1094-bp LTR-containing chimeric molecule. As expected, the band is missing in the
GX0101ΔLTR DNA in lane 8. Lanes 9 and 10—primer pair # 6 was used for the
ampliﬁcation of the 599-bp LTR-containing chimeric molecule, absent in the LTR-
deleted virus in lane 10. Lanes 11 and 12—primer pair #8 was used for the ampliﬁcation
of the 2280-bp gB gene. Lanes 13 and 14—primer pair #2 was used for ampliﬁcation of
REV-LTR with its ﬂanking sequences. The band in lane 14 is smaller than that in lane 13,
indicating the loss of LTR in GX0101ΔLTR.
274 A. Sun et al. / Virology 397 (2010) 270–276was prepared using commercially available kits (Qiagen) according to
the standard protocols (Sambrook and Russell, 2001).
Conﬁrmation of the deletion of LTR by PCR analysis
The integrity of the MDV genome and deletion of the REV-LTR
(Fig. 2) from the GX0101ΔLTR-BAC DNA were analyzed by PCR using
primer pairs that amplify different regions of the genome as shown
in Table 1.
Reconstitution of MDV from GX0101ΔLTR-BAC DNA
For the rescue of GX0101ΔLTR viruses, the BAC DNA was
transfected into CEF using Lipofectamine according to manufacturer's
instructions (Invitrogen). Brieﬂy, 1 μg DNA and 10 μl Lipofectamine
were each diluted in 100 μl opti-MEM in separate tubes. The two
solutions were mixed gently and left at room temperature for 45 min,
after which the volumewas increased to 1ml. CEFwere seeded into 6-
well plates 1 day before transfection, and after washing themonolayer
twice with opti-MEM, the DNA/lipofectamine mixture was added to
eachwell. After incubating the cells at 37 °C for 6 h, 1ml growthmediawas added to each well. The transfected cells were incubated for
several days until speciﬁc viral plaques appeared. After four round
passages to enrich the viral titers, GX0101ΔLTR virus stocks were
stored in liquid nitrogen.
Indirect immunoﬂuorescence assay (IFA) of GX0101ΔLTR virus
IFA was performed as described previously using MDV-speciﬁc
monoclonal antibody H19 (Lee et al., 1983). Uninfected CEF was used
as a negative control.
Pathogenicity of GX0101 and GX0101ΔLTR viruses
Bird experiments were carried out on 1-day-old MDV-antibody
negative, speciﬁc-pathogen-free birds (from SPAFAS in Jinan, a joint
venture with US Riverside). Birds were randomly divided into 3
groups and kept in 3 isolators under positive ﬁltered air. In the
experiment, 62 birds given HVT vaccine at 1 day of age were divided
into two groups of 31 birds each, and inoculated intra-abdominally
with 1000 PFU of GX0101 or GX0101ΔLTR viruses at 5 days of age.
Additionally, 17 non-vaccinated non-infected birds each were kept in
the same isolators as sentinel in contact birds to evaluate the
horizontal transmission. A group of 16 birds inoculated with
uninfected CEF was used as negative control. Birds were inspected
regularly for any clinical signs and mortality or sacriﬁced at the end of
the trial. At the end of 100 days, all the birds were evaluated for gross
and histological lesions at necropsy. Cumulative mortality rates were
used to determine the pathogenicity of each virus.
Measurement of body weights
Body weight measurements of the birds in different groups were
made on days 10, 14, 21, 28, 35, 42 and 56 post-infection in order to
evaluate the effect of infection on growth rates.
Immunosuppressive effects of the two viruses
In order to evaluate the immunosuppressive effects of the two
viruses, 9-day-old birds were vaccinated with NDV and AIV-H9
inactivated vaccines according to the previously described procedure
(Sun et al., 2007). Serum samples collected 35 days after vaccination
were used to measure the hemagglutination inhibition (HI) antibody
titers to NDV and AIV-H9.
Fig. 3. Sequence of the PCR-ampliﬁed region containing the integration junction of the LTR in GX0101 and GX0101DLTR clones. (A) Chimeric molecule ampliﬁed from GX0101
showing the 539-bp REV-LTR insert (GenBank accession number GQ870289) with its ﬂanking MDV sequences (underlined). The nucleotides “C” and “A” corresponding to the
positions 153175–153176 of Md5 genome are indicated by arrows. A consensus TATA box present in the LTR sequences is boxed. (B) The sequence of the corresponding region
ampliﬁed from the GX0101ΔLTR construct from which the LTR is deleted. The regions representing the MDV fragments are underlined. The sequence of the FRT sites (black italic
letters) left during the construction of the GX0101ΔLTR with its ﬂanking fragments from KanR cassette is also shown.
275A. Sun et al. / Virology 397 (2010) 270–276Determination of viremia
Blood samples in anticoagulants were collected from six birds of
each group on days 7, 14, 21, 28, 38, 76 and 96 post-infection, and 1ml
from each bird was mixed with 9 ml of DMEM. Blood suspensions
were centrifuged at 500×g for 5 min to separate white blood cells
from red blood cells. By such centrifugation, almost all white blood
cells were saved in the supernatants with some red blood cells. The
supernatants containing the leukocytes from each bird were used to
inoculate two duplicate 35-mm plates with CEF monolayers. Viral
plaques detected in IFA with monoclonal antibody H19 were counted
6 days post-infection. IFA was performed as previously described (Lee
et al., 1983) with modiﬁcations. Brieﬂy, infected cells were washed
with PBS and ﬁxed with ethanol/acetone solution (4:6) at room
temperature for 10 min. After removing the ﬁxing solution, the cells
were air dried and incubatedwithmonoclonal antibody H19 (1:1000)
for 1 h at 37 °C. Following three washes with PBS, the cells were
incubated with goat anti-mouse FITC labeled secondary antibodies
(Sigma) for 1 h. Cells were further washed 3 times with PBS and
examined under a ﬂuorescence microscope. The MDV-speciﬁc
plaques were counted in each 35-mm plates and the viremia titers
were expressed as pfu per ml blood.
Horizontal transmission of GX0101 and GX0101ΔLTR viruses
The presence of MDV genomic DNA in feather tips was detected by
dot blot hybridization with MDV-speciﬁc probe using methods as
described previously (Cui et al., 1991). Brieﬂy, 6–8 pieces of 1- to 2-
mm-long feather tips from each birdwere collected at intervals from 7
days to 35 days post-infection. They were incubated in 0.5 ml of
digestion buffer (100 mM NaCl, 10 mM Tris–HCl pH 8.0, 0.25 mM
EDTA, 0.5% SDS, and 100 μg/ml proteinase K) overnight at 55 °C. DNA
in solution was extracted by phenol/chloroform mixture and then
precipitatedwith alcohol, and dissolved into 10 μl of TE buffer (10mM
Tris–HCl, 0.1 mM EDTA, pH 8.0). One microliter of DNA solution from
each sample was added onto a piece of nitrocellulose paper and
denatured by 0.1 M NaOH solution, dried in an oven at 80 °C for 2 h.
Plasmid DNA containing MDV-1-speciﬁc pp38 gene fragment (Cui et
al., 1991) labeled using DIG nucleic acid labeling and Detection kit
(Roche) was used as the probe following manufacturer's instructions.For further comparison of the horizontal transmission ability of the
two viruses, a second experiment (Experiment 2) was conducted
identical to the one described in Section 1.5 above except that SPF
birds used were not vaccinated with HVT before challenged with
GX0101 or GX0101ΔLTR virus (Fig. 3).
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